Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Statements of Changes in Shareholders' Deficit

v3.20.2
Statements of Changes in Shareholders' Deficit - USD ($)
Preferred Stock [Member]
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2016 $ 9,424 $ 166,723 $ 1,980,344 $ (2,560,440) $ (403,949)
Balance, shares at Dec. 31, 2016 3,333,471 63,747,504      
Conversion of preferred shares into ordinary shares (Note 10B) $ (9,475) $ 9,475
Conversion of preferred shares into ordinary shares (Note 10B), shares (3,351,850) 3,351,850      
Exercise of warrants, net of issuance expenses and amount classified to equity upon exercise $ 4,625 1,058,475 1,063,100
Exercise of warrants, net of issuance expenses and amount classified to equity upon exercise, shares 1,665,000      
Issuance of ordinary shares, net of issuance expenses (Note 10C2) $ 3,015 559,538 562,553
Issuance of ordinary shares, net of issuance expenses (Note 10C2), shares 1,061,125      
Exercise of stock options into ordinary shares $ 226 226
Exercise of stock options into ordinary shares, shares 81,432      
Issuance of ordinary shares to service providers $ 897 2,904 3,801
Issuance of ordinary shares to service providers, shares 350,000      
Stock-based compensation (Note 11) $ 51 109,957 110,008
Stock-based compensation (Note 11), shares 18,379      
Commitment for issuance of fixed number of ordinary shares and stock warrants upon modification of terms relating to convertible bridge loans transactions (Note 7)        
Issuance of ordinary shares as partial settlement of financial liability (Note 9D)        
Issuance of ordinary shares (Note 10B4), shares         81,432
Net loss for the year (2,675,372) $ (2,675,372)
Balance at Dec. 31, 2017 $ 184,961 3,711,218 (5,235,812) (1,339,633)
Balance, shares at Dec. 31, 2017 70,256,911      
Exercise of warrants, net of issuance expenses and amount classified to equity upon exercise $ 1,928 451,295 453,223
Exercise of warrants, net of issuance expenses and amount classified to equity upon exercise, shares 722,500      
Exercise of stock options into ordinary shares $ 1,656 (1,656)  
Exercise of stock options into ordinary shares, shares 620,521      
Stock-based compensation (Note 11) 47,672 47,672
Stock-based compensation (Note 11), shares      
Issuance of units consisting of ordinary shares and stock warrants (Note 10B3) $ 2,134 78,211 80,345
Issuance of units consisting of ordinary shares and stock warrants (Note 10B3), shares 800,000      
Commitment for issuance of fixed number of ordinary shares and stock warrants upon modification of terms relating to convertible bridge loans transactions (Note 7)        
Issuance of ordinary shares as partial settlement of financial liability (Note 9D)        
Net loss for the year (457,541) (457,541)
Balance at Dec. 31, 2018 $ 190,679 4,286,740 (5,693,353) (1,215,934)
Balance, shares at Dec. 31, 2018 72,399,932      
Issuance of ordinary shares to service providers $ 12,857 742,143 755,000
Issuance of ordinary shares to service providers, shares 4,500,000      
Stock-based compensation (Note 11) 207,541 207,541
Stock-based compensation (Note 11), shares      
Issuance of ordinary shares as consideration for unit consisting of investment in affiliated company and right to obtain control over affiliated company (Note 3) $ 51,391 2,466,789 2,518,180
Issuance of ordinary shares as consideration for unit consisting of investment in affiliated company and right to obtain control over affiliated company (Note 3), shares 17,986,999      
Issuance of unit consisting of ordinary shares and stock warrants upon partial extinguishment of loans from shareholders (Note 6) $ 10,000 1,763,493 1,773,493
Issuance of unit consisting of ordinary shares and stock warrants upon partial extinguishment of loans from shareholders (Note 6), shares 3,500,000      
Partial conversion of convertible bridge loans into ordinary shares (Note 7) $ 5,177 330,344 $ 335,521
Partial conversion of convertible bridge loans into ordinary shares (Note 7), shares 1,811,864     1,811,864
Classification of derivative warrants liability into equity as result of partial conversion of convertible bridge loans into ordinary shares (Note 7) 60,365 $ 60,365
Commitment for issuance of fixed number of ordinary shares and stock warrants upon modification of terms relating to convertible bridge loans transactions (Note 7) 162,405 162,405
Issuance of stock warrants to lenders upon convertible bridge loans transactions (Note 7) 290,875 290,875
Beneficial conversion feature upon modification of terms of convertible bridge loans (Note 7) 79,849 79,849
Issuance of ordinary shares as partial settlement of financial liability (Note 9D) $ 357 12,143 12,500
Issuance of ordinary shares as partial settlement of financial liability (Note 9D), shares 125,000      
Commitment for issuance of fixed number of ordinary shares to service provider (Note 9F) 230,908 230,908
Issuance of ordinary shares (Note 10B4) $ 8,429 286,571 295,000
Issuance of ordinary shares (Note 10B4), shares 2,950,000      
Issuance of ordinary shares to the Company's chairman of the Board of Directors (Note 10B5) $ 857 59,143 60,000
Issuance of ordinary shares to the Company's chairman of the Board of Directors (Note 10B5), shares 300,000      
Net loss for the year       (11,814,515) (11,814,515)
Balance at Dec. 31, 2019 $ 279,747 $ 10,979,309 $ (17,507,868) $ (6,248,812)
Balance, shares at Dec. 31, 2019 103,573,795